|

Sonesitatug vedotin Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Also known as: AZD0901, Sone-Ve

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • AstraZeneca2
  • Jeeyun Lee1

Indications

  • Cancer3
  • Gastroesophageal Adenocarcinoma1
  • Gastroesophageal Junction Adenocarcinoma1
  • Stomach Neoplasms1
  • Gastric Cancer1

Other1 trial

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
Phase 2

Birmingham, Alabama1 trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site

Phase 3

Newark, Delaware1 trial

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.